Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Juliette Lambert, Sylvie Castaigné, Claude Preudhomme et al.|Haematologica|2018

Cited by 349